Topic · Hepatitis B Virus Studies
Most cited papers in Hepatitis B Virus Studies
What are the most cited papers in Hepatitis B Virus Studies?
The most cited paper in Hepatitis B Virus Studies is "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide" (Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al., 1999), with 9,115 citations. Next come "Management of Hepatocellular Carcinoma: An Update Δσ" (8,176) and "Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome" (6,911).
Showing 50 of 99 papers. Every paper with more than 1,353 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Human papillomavirus is a necessary cause of invasive cervical cancer worldwide Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al. · The Journal of Pathology | Sep 1999 | 9,115 |
| 2 | Management of Hepatocellular Carcinoma: An Update Δσ Jordi Bruix, Morris Sherman · Hepatology | 19 Jan 2011 | 8,176 |
| 3 | Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome Qui‐Lim Choo, George C. Kuo, Amy J. Weiner et al. · Science | 21 Apr 1989 | 6,911 |
| 4 | Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Michael Peter Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet | Sep 2001 | 6,056 |
| 5 | Management of Hepatocellular Carcinoma * Jordi Bruix, Morris Sherman · Hepatology | 26 Oct 2005 | 5,904 |
| 6 | Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Ann‐Lii Cheng et al. · The Lancet Oncology | 18 Dec 2008 | 5,881 |
| 7 | Hepatocellular carcinoma Alejandro Forner, María Reig, Jordi Bruix · The Lancet | 4 Jan 2018 | 5,713 |
| 8 | EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection Pietro Lampertico, Kosh Agarwal, Thomas Berg et al. · Journal of Hepatology | 18 Apr 2017 | 5,528 |
| 9 | Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma Severin Gloor, Kai Oliver Jensen, Stefan Breitenstein et al. · Case Reports in Gastroenterology | 21 Mar 2017 | 5,376 |
| 10 | The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets Gisa Gerold, Thomas Pietschmann · Digestive Diseases | 2014 | 4,864 |
| 11 | Liver fibrosis Ramon A. Bataller, David A. Brenner · Journal of Clinical Investigation | Feb 2005 | 4,815 |
| 12 | Hepatocellular Carcinoma Augusto García Villanueva · New England Journal of Medicine | 10 Apr 2019 | 4,745 |
| 13 | Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases Jorge A. Marrero, Laura Kulik, Claude B. Sirlin et al. · Hepatology | 6 Apr 2018 | 4,682 |
| 14 | A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C Chun‐Tao Wai, Joel K. Greenson, Robert J. Fontana et al. · Hepatology | 25 Jul 2003 | 4,422 |
| 15 | Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance Norah A. Terrault, Anna S. Lok, Brian J. McMahon et al. · Hepatology | 5 Feb 2018 | 4,390 |
| 16 | Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference Jordi Bruix, Morris Sherman, Josep Maria Llovet et al. · Journal of Hepatology | Sep 2001 | 4,098 |
| 17 | Papillomaviruses and cancer: from basic studies to clinical application Harald zur Hausen · Nature reviews. Cancer | May 2002 | 4,062 |
| 18 | Hepatocellular carcinoma Josep Maria Llovet, Andrew Kenneth Burroughs, Jordi Bruix · The Lancet | Dec 2003 | 3,620 |
| 19 | The causal relation between human papillomavirus and cervical cancer Francesc Xavier Bosch, Attila Tibor Lorincz, N Munoz et al. · Journal of Clinical Pathology | Apr 2002 | 3,609 |
| 20 | Hepatocellular Carcinoma Hashem B. El‐Serag · New England Journal of Medicine | 21 Sep 2011 | 3,545 |
| 21 | Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma Hashem B. El‐Serag · Gastroenterology | 24 Apr 2012 | 3,459 |
| 22 | Effect of pegylation on pharmaceuticals J. Milton Harris, Robert B. Chess · Nature Reviews Drug Discovery | 28 Feb 2003 | 3,437 |
| 23 | Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level Chien‐Jen Chen · JAMA | 3 Jan 2006 | 3,164 |
| 24 | Chronic hepatitis B Anna S. Lok, Brian J. McMahon · Hepatology | 26 Jan 2007 | 3,096 |
| 25 | Human papillomavirus and cervical cancer MARK H. SCHIFFMAN, Philip E. Castle, José Jerónimo et al. · The Lancet | Sep 2007 | 3,039 |
| 26 | Hepatitis C Virus Infection Georg Michael Lauer, Bruce D. Walker · New England Journal of Medicine | 5 Jul 2001 | 2,985 |
| 27 | Diagnosis, management, and treatment of hepatitis C: An update # † ‡ Marc G. Ghany, Doris B. Strader, David L. Thomas et al. · Hepatology | 2 Dec 2008 | 2,985 |
| 28 | HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS R. Palmer Beasley, Chia‐Chin Lin, Lu‐Yu Hwang et al. · The Lancet | Nov 1981 | 2,879 |
| 29 | Rising Incidence of Hepatocellular Carcinoma in the United States Hashem B. El‐Serag, Andrew C. Mason · New England Journal of Medicine | 11 Mar 1999 | 2,871 |
| 30 | Chronic hepatitis B: Update 2009 # Anna S. Lok, Brian J. McMahon · Hepatology | 28 Jul 2009 | 2,851 |
| 31 | Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C Stephanos J. Hadziyannis, Hoel Sette, Timothy R. Morgan et al. · Annals of Internal Medicine | 2 Mar 2004 | 2,842 |
| 32 | Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line Volker Lohmann, Frank Körner, Jan Oliver Koch et al. · Science | 2 Jul 1999 | 2,814 |
| 33 | Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 Aparna Schweitzer, Johannes Horn, Rafael Mikolajczyk et al. · The Lancet | 28 Jul 2015 | 2,802 |
| 34 | Global epidemiology of hepatitis C virus infection Colin W. Shepard, Lyn Finelli, Miriam J. Alter · The Lancet Infectious Diseases | 25 Aug 2005 | 2,769 |
| 35 | Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Takaji Wakita, Thomas Pietschmann, Takanobu Kato et al. · Nature Medicine | 12 Jun 2005 | 2,753 |
| 36 | Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures Daniel Lavanchy · Journal of Viral Hepatitis | 20 Feb 2004 | 2,663 |
| 37 | Hepatocellular carcinoma in cirrhosis: Incidence and risk factors Giovanna Fattovich, Tommaso Stroffolini, I. Zagni et al. · Gastroenterology | Nov 2004 | 2,615 |
| 38 | An inventory for assessing different kinds of hostility. Arnold H. Buss, Ann Durkee · Journal of Consulting Psychology | 1957 | 2,615 |
| 39 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Shiv Kumar Sarin et al. · Hepatology International | 13 Nov 2015 | 2,603 |
| 40 | The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide Joseph F. Perz, Gregory L. Armstrong, Leigh A. Farrington et al. · Journal of Hepatology | 24 Jun 2006 | 2,597 |
| 41 | Hepatitis B Virus Infection William M. Lee · New England Journal of Medicine | 11 Dec 1997 | 2,588 |
| 42 | Classification of chronic hepatitis: Diagnosis, grading and staging Valeer J. Desmet, Michael A. Gerber, Jay H. Hoofnagle et al. · Hepatology | Jun 1994 | 2,578 |
| 43 | Primary liver cancer: Worldwide incidence and trends Francesc Xavier Bosch, Josepa Ribes, Mireia Díaz et al. · Gastroenterology | Nov 2004 | 2,507 |
| 44 | Hepatitis B Virus Infection — Natural History and Clinical Consequences Don Ganem, Alfred M. Prince · New England Journal of Medicine | 10 Mar 2004 | 2,384 |
| 45 | Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet | Oct 1998 | 2,335 |
| 46 | Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease Yun‐Fan Liaw, Joseph J.�Y. Sung, Wan Cheng Chow et al. · New England Journal of Medicine | 6 Oct 2004 | 2,281 |
| 47 | Complete Replication of Hepatitis C Virus in Cell Culture Brett D. Lindenbach, Matthew J. Evans, Andrew J. Syder et al. · Science | 9 Jun 2005 | 2,244 |
| 48 | Sampling Variability of Liver Fibrosis in Chronic Hepatitis C Pierre Bédossa, Delphine Dargère, Valérie Paradis · Hepatology | 25 Nov 2003 | 2,234 |
| 49 | Epidemiology of Hepatocellular Carcinoma Katherine A. McGlynn, Jessica L. Petrick, Hashem B. El‐Serag · Hepatology | 22 Apr 2020 | 2,217 |
| 50 | Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Masao Omata et al. · Hepatology International | 15 Jun 2017 | 2,208 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.